About The Founder
Harry ‘Doc’ Kloor is CEO and Co-Founder of Beyond Imagination – a company that will bring general purpose humanoid Avatars to the world, enabling near instantaneous transportation. He is an American scientist, inventor, film producer, director, writer, and entrepreneur. Kloor was the first (and still the only) person to be awarded two PhDs simultaneously in two distinct academic disciplines. He holds PhDs in Physics and in Chemistry, both earned at Purdue University. In recognition of this achievement he was named ABC person on the week in August 1994. Dr. Kloor is a recognized leader in bringing science to the public, and science consultant for NASA, CIA, and fortune 500 companies.
Kloor has worked with large number of scientific organizations, universities, and companies to advance exponential technologies ranging from robotics, holographic capture, virtual and augmented reality, artificial intelligence, deep machine learning, sensor networks, IOT, haptics, etc.
In 2016, Kloor returned to XPRIZE Foundation, as Bold Innovator bringing his decades long mission of advancing Avatar technologies to XPRIZE. As Bold Innovator he created the Avatar XPRIZE concept and developed it’s design, which on October 1, 2016 was presented and voted one of the three top prize designs. Dr. Kloor then raised a 22M commitment from ANA to fund the Avatar XPRIZE. This prize was formally announced on March 12th, 2018 at South by South West.
Kloor is also founder and CEO of Jupiter 9 Productions. He was one of the five original founding team members of the famed Ansari XPRIZE, and served on the founding team for Singularity University and former part-time instructor. He was also the chief science adviser for the XPRIZE Organization, advising XPRIZE Chairman and CEO Dr. Peter H. Diamandis on science and technology issues. In 2011, Kloor was one of the chairs of the DARPA’s 100 Year Starship study. He was one of the three co-founders of the Rocket Racing League, and is co-founder of Mixed Reality company, a software security and content company, and a Stem-Cell cord blood company.
Dr. Kloor has advised in the area of Blockchain and crypto-currency for many years, and serves as advisor on several ICO offerings.
Dr. Kloor works in the advancement of advanced treatments and technologies in various areas of healthcare, and is a member of the Brain Mapping and Therapeutics Society, for which he is also the Co-Chair of their annual awards and fund raising gala.
Kloor also co-founded the company Universal Consultants, where he served as chief science consultant, providing guidance to clients in the development of new technological products, patents, and policy positions. These clients include NASA, the National Security Agency, the American Institute of Chemical Engineers, the US Senate, American Medical Association, and Jet Propulsion Laboratories.
Kloor is a film writer, director and producer. He has written for numerous Hollywood studios and various TV and Film Projects, including but not limited to Star Trek: Voyager, Godzilla the animated series and was the story editor for Gene Roddenberry’s Earth: Final Conflict, a series he co-created/developed. Most recently Kloor has been writing features – including a film titled ILL WIND, based on Kevin J. Anderson’s and Doug Beason’s book for 20th Century Fox Studios, and Carson of Venus based on Edgar Rice Burroughs book of the same title for Bold Films. He is presently developing John Carter of Mars with Tim Kring (creator of such famed TV series as HEROES, TOUCHED, and DIG) and Saga of the Seven Suns for Eone.
Kloor helped create Taiwan’s animation industry, bringing, Quantum Quest, the first big animation film to Taiwan that starred major Hollywood stars. Quantum Quest stars the voice talents of Chris Pine, Samuel L. Jackson, Hayden Christensen, James Earl Jones, Amanda Peet, Abigail Breslin and many others. QQ also features the voice of Neil Armstrong; his one and only film. Dr. Kloor co-created the series Earth Final Conflict for Tribune/Alliance, and served as producer and writer on the series.